Attenuation of DNA charge transport by compaction into a nucleosome core particle

Por Bjorklund, Chad C., Davis, William B.
Publicado em 2006

Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase is Mediated by Point Mutations of p53, but can be Overcome with the p53 Targeting Agent RITA

Por Jones, Richard J., Bjorklund, Chad C., Baladandayuthapani, Veerabhadran, Kuhn, Deborah J., Orlowski, Robert Z.
Publicado em 2012

The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1

Por Jones, Richard J., Gu, Dongmin, Bjorklund, Chad C., Kuiatse, Isere, Remaley, Alan T., Bashir, Tarig, Vreys, Veronique, Orlowski, Robert Z.
Publicado em 2013

Evidence of a Role for Activation of Wnt/β-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide

Por Bjorklund, Chad C., Ma, Wencai, Wang, Zhi-Qiang, Davis, R. Eric, Kuhn, Deborah J., Kornblau, Steven M., Wang, Michael, Shah, Jatin J., Orlowski, Robert Z.
Publicado em 2011

Inhibition of the MDM2 E3 Ligase Induces Apoptosis and Autophagy in Wild-Type and Mutant p53 Models of Multiple Myeloma, and Acts Synergistically with ABT-737

Por Gu, Dongmin, Wang, Shuhong, Kuiatse, Isere, Wang, Hua, He, Jin, Dai, Yun, Jones, Richard J., Bjorklund, Chad C., Yang, Jing, Grant, Steven, Orlowski, Robert Z.
Publicado em 2014

A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples

Por Ren, Yan, Wang, Maria, Couto, Suzana, Hansel, Donna E., Miller, Karen, Lopez-Girona, Antonia, Bjorklund, Chad C., Gandhi, Anita K., Thakurta, Anjan, Chopra, Rajesh, Breider, Michael
Publicado no Appl Immunohistochem Mol Morphol (2016)

Evidence of a Role for CD44 and Cell Adhesion in Mediating Resistance to Lenalidomide in Multiple Myeloma: Therapeutic Implications

Por Bjorklund, Chad C., Baladandayuthapani, Veerabhadran, Lin, Heather Y., Jones, Richard J., Kuiatse, Isere, Wang, Hua, Yang, Jing, Shah, Jatin J., Thomas, Sheeba K., Wang, Michael, Weber, Donna M., Orlowski, Robert Z.
Publicado em 2013

Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

Por Zhu, Yuan Xiao, Braggio, Esteban, Shi, Chang-Xin, Bruins, Laura A., Schmidt, Jessica E., Van Wier, Scott, Chang, Xiu-Bao, Bjorklund, Chad C., Fonseca, Rafael, Bergsagel, P. Leif, Orlowski, Robert Z., Stewart, A. Keith
Publicado em 2011

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy Against Waldenström’s Macroglobulinemia

Por Kuiatse, Isere, Baladandayuthapani, Veerabhadran, Lin, Heather Y., Thomas, Sheeba K., Bjorklund, Chad C., Weber, Donna M., Wang, Michael, Shah, Jatin J., Zhang, Xing-Ding, Jones, Richard J., Ansell, Stephen M., Yang, Guang, Treon, Steven P., Orlowski, Robert Z.
Publicado no Clin Cancer Res (2015)

Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma

Por Kuhn, Deborah J., Berkova, Zuzana, Jones, Richard J., Woessner, Richard, Bjorklund, Chad C., Ma, Wencai, Davis, R. Eric, Lin, Pei, Wang, Hua, Madden, Timothy L., Wei, Caimiao, Baladandayuthapani, Veerabhadran, Wang, Michael, Thomas, Sheeba K., Shah, Jatin J., Weber, Donna M., Orlowski, Robert Z.
Publicado em 2012